Daily confirmed COVID-19 cases (n = 61,993) and smoothed trends for the median age of all the cases, hospitalized cases, and deceased cases. by Diego Casas-Deza (11819838)

Subjects:

Equivalent elastic modulus of the capsule under case 1 and case 3. by Hongliang Zhang (149767)

Equivalent Poisson’s ratio of the capsule under case 1 and case 3. by Hongliang Zhang (149767)

Distribution of cases/non cases per outcome. by Shilpa Darivemula (19797310)

Simulation results–Case 3. by Tuan Anh Nguyen (121944)

Subjects:

Increase Learning Agility through Unsolvable Cases by Siti Noorbaiyah Binti Abdul Malek (9589485)

“…The study of law and regulations might seem doctrinal, but the application of it requires a mix of both subjective and objective perspectives. Three case studies were designed to facilitate their learning. …”

Case #3 by Bálint Lakatos (10535348)

Current parameters for the 3 load cases. by Chiemela Victor Amaechi (20469041)

Wave parameters for the 3 load cases. by Chiemela Victor Amaechi (20469041)

Numerical cases. by Kaywan Othman Ahmed (17705927)

Subjects:

Simulated estimates of number of silicosis cases and annual tuberculosis (TB) cases at cumulative RCS distributions of increasing mean values. by Patrick Howlett (2612374)

“…<p>Silicosis prevalence and TB incidence was estimated for sample sizes of 10,000 at mean RCS values between 0 and 20, at intervals of 0.01 mg/m³-year. Variables in the model are held constant, unless otherwise stated, at values of: a baseline silicosis prevalence of 2%, an increased odds of 1.3 of silicosis per 1 mg/m³-year increase in RCS exposure, a baseline TB incidence of 200 cases per 100,000 per year, an increased odds of 1.05 of TB per 1 mg/m³-year increase in RCS exposure, an increased odds of TB of 4x in those with silicosis, a randomly distributed baseline prevalence of HIV of 2% and an increased odds of TB of 4x in those with HIV. …”

Extreme cases. by Qingshu Xia (19429473)

Frequency responses for case 3. by Mahmoud M. Hussein (16965014)

Fluctuation sources for case 3. by Mahmoud M. Hussein (16965014)

Cases. by Longfei Dong (17616195)

Case. by Seungyoon Paik (14659575)

In-hospital cases per prescription case. by Anna Horwitz (771335)

Distribution of death cases. by Li Chen (5749)

Subjects:

Number of cases tested for both PCV2 and PCV3 and number of cases and percentage of positive cases for both analytes over time (2017–2023). by Guilherme Cezar (17816844)

Subjects:

Numerical examples for Case 3 where . by Guanqun Ni (6260393)